Know Cancer

or
forgot password

Chemotherapy-Related Toxicities In Ovarian Cancer Patients: Preference Assessments of Patients, Family Members, Ancillary Staff and Gynecologic Oncologists, and Patients' Quality of Life


N/A
18 Years
N/A
Open (Enrolling)
Female
Ovarian Cancer

Thank you

Trial Information

Chemotherapy-Related Toxicities In Ovarian Cancer Patients: Preference Assessments of Patients, Family Members, Ancillary Staff and Gynecologic Oncologists, and Patients' Quality of Life


Patients in this study will be recruited from the Gynecologic Oncology Clinic waiting area.
All participants (patients, family and clinical caregivers, control group women with no
cancer) in this study will take part in an interview to see how they feel about the
different side-effects of chemotherapy. The interview will involve reading short
descriptions of the side-effects and then answering some questions that ask for an opinion.
The actual interview will take about 30-45 minutes to complete. The interviews will either
take place in private conference rooms in the clinic or in private rooms at the Ambulatory
Treatment Center (ATC).

Patients will also be given quality of life and symptom assessment questionnaires. The
questionnaires are simple to read and quick to answer. The questionnaire takes about 15
minutes to complete.

The participant's involvement in this study is limited to the questionnaire/interview. Once
that is done, the participant is finished with the study.

This is an investigational study. A total of 288 people will take part in this study. All
will be enrolled at M. D. Anderson.


Inclusion Criteria:



1. Women with epithelial ovarian cancer presenting to the UTMDACC Gynecologic Oncology
Clinic who are currently undergoing chemotherapy

2. Women with a history of epithelial ovarian cancer presenting to the UTMDACC
Gynecologic Oncology Clinic who are seen in follow-up

3. Women who are at least 18 years of age

4. Women who speak English

5. Clinical caregivers of patients with ovarian cancer (UTMDACC gynecologic oncologists,
UTMDACC gynecologic medical oncologists, UTMDACC registered nurses and licensed
vocational nurses in the UTMDACC Gynecology Clinic, and UTMDACC gynecologic oncology
fellows and residents)

6. Familial caregivers of patients with ovarian cancer (primary caregiver)

Exclusion Criteria:

1. Participants who are non-English speakers

2. Participants who are less than 18 years of age

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Qualitative information on how ovarian cancer patients, their family members, and doctors and nurses feel about the side-effects of chemotherapy.

Outcome Time Frame:

8 Years

Safety Issue:

No

Principal Investigator

Diane C. Bodurka, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

M.D. Anderson Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

GYN00-409

NCT ID:

NCT00508378

Start Date:

January 2001

Completion Date:

Related Keywords:

  • Ovarian Cancer
  • Ovarian Cancer
  • Quality of Life
  • Chemotherapy Side-Effects
  • Interview
  • Questionnaire
  • Caregivers
  • Ovarian Neoplasms

Name

Location

UT MD Anderson Cancer CenterHouston, Texas  77030